Presentation by Adil Zanfari, President, Genpharma, Morocco made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

1. PHARMACEUTICAL
CHALLENGES IN
AFRICA
By ADIL ZANFARI, PRESIDENT
EAHIC London
1

2. FROM AFRICANS TO AFRICANS
A PRAGMATIC VISION ABOUT THE FUTURE OF
PHARMACEUTICAL INDUSTRY IN AFRICA
THE MOROCCAN CASE

3. The Moroccan Pharmaceutical Market:
a high potential industry in motion
•
•
•
•
32 pharmaceuticals industrial
plants
300 millions units manufactured
in 2011
6000 products presentations
marketed
65% of total medicines consumed
are produced locally
• + 40 000 direct and indirect
employment
• 2012 Private market : 1 billion USD
•
2013 Tender market : 300 millions
USD
•
2011 Export pharmaceutical
market : 45 millions USD
•
40 export Countries in Africa,
Middle East, Europe
• Morocco included into the
European pharmaceutical Zone
• EDMQ European Pharmacopoeia applied
• Morocco National Control Laboratory ( LNCM ) is the only African member of the
European network of official medecine Control laboratories ( OMCLs EDMQ )

4. The EMERGENCE Plan: the Morocco
Government industrial strategy to
strengthen country attractiveness
• Launched in 2007 to magnify the
competitive advantages of
Morocco over other developing
countries
• 2 Main strategic goals:
 Accelerate the creation of
sustainable added value wealth
 Build up powerful industrial
activities to boost-up exports
• 8 specific industries covered:








Offshoring
Automotive
Electronics
Aeronautic
Agro food
textile / leather
Pharmaceutical Industry
Chemistry
KEY ISSUE => PHARMACEUTICAL INDUSTRY IS INCLUDED
SINCE 20 FEBRUARY 2013

5. The Pharmaceutical industry is now
fully part of the strategic investment plan
Moroccan Government
Pharmacists
Medical Doctors
National Association of Generic
Pharmaceutical Producers
PHARMACEUTICAL INDUSTRY HAS BEEN
ADDED IN THE EMERGENCE PLAN IN 2013 !

6. The EMERGENCE Plan for Pharmaceutical
industry: a collective & focused approach
to unleash the local potential
 Partnership between Private sector & Public sector
 First class international and national consulting firms involved
 One strong Objective: Develop access to affordable medicines
 Key Target : Accelerate both local market growth and export development
 Milestone 1: Achieve 1 to 2 billion USD sales in Pharma Export by 2023
 Milestone 2: Increase local pharma market from 1 to 2 billion USD by 2023
 Targeted outcome 1: Create + 5,000 additional direct employement
 Targeted outcome 2: Create + 15,000 – 20,000 indirect employement

7. The Pharmaceutical EMERGENCE plan
translates into a multidimensional approach
to improve National health system
Strengthen & upgrade the local pharmaceutical industry to match
USD FDA, AFSAPS, TGA, UK MHRA, MCC & GCC certifications
Develop
outsourcing R&D
Main Goal: Strengthen the ability of
National Health system to address the
needs of Moroccan population
Develop Clinical
trials programs
(CRO)
Launch large scale
training &
education of
pharma teams
Increase impact of
Generics through
Export to Africa &
Middle East
Develop
Manufacturing
offshoring (CMO)
Dedicate investment
funds to sponsor the
project (100 M USD)
Upgrade local
legislation to match
European pharma rules
Attract mid size
Pharma companies
to relocate
production in
Morocco

8. The Pharmaceutical EMERGENCE plan is
also seeking growth through targeting 4 key
segments representing a total potential of
100 Million USD

9. In fact the Pharmaceutical EMERGENCE
plan constitutes a strong lever to
accelerate cost effective achievement of
competitive economy of scale
ECONOMY OF SCALE: A KEY INGREDIENT TO SECURE
AFFORDABLE DRUGS TO POPULATION !

11. 254 – 260 ZI 24000 EL JADIDA MOROCCO
Tel : +212 523 35 29 83
FAX: +212 523 35 29 93
www.genpharma.ma
11